✨ Medicines Consent Notices




3840 NEW ZEALAND GAZETTE, No. 154 18 NOVEMBER 2010

Product:
Active Ingredients:
Duro-Tuss Chesty Cough Liquid Forte
Bromhexine hydrochloride 0.8mg/mL
Guaifenesin 20mg/mL
Dosage Form:
Solution
New Zealand Sponsor:
iNova Pharmaceuticals (New Zealand) Limited
Manufacturer:
iNova Pharmaceuticals (Australia) Pty Limited, Thornleigh, Australia

Product:
Active Ingredient:
Hayzep
Desloratadine 5mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Mylan New Zealand Limited
Manufacturer:
McDermott Laboratories t/a Gerard Laboratories, Dublin, Ireland

Product:
Active Ingredient:
Mestane
Exemestane 25mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturer:
Douglas Pharmaceuticals (Fiji) Limited, Nadi, Fiji

Product:
Active Ingredient:
Neupro
Rotigotine 4.5mg
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Pharmabroker Sales Limited
Manufacturer:
LTS Lohmann Therapie-Systeme AG, Andernach, Germany

Product:
Active Ingredient:
Neupro
Rotigotine 9mg
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Pharmabroker Sales Limited
Manufacturer:
LTS Lohmann Therapie-Systeme AG, Andernach, Germany

Product:
Active Ingredient:
Neupro
Rotigotine 13.5mg
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Pharmabroker Sales Limited
Manufacturer:
LTS Lohmann Therapie-Systeme AG, Andernach, Germany

Product:
Active Ingredient:
Neupro
Rotigotine 18mg
Dosage Form:
Transdermal patch
New Zealand Sponsor:
Pharmabroker Sales Limited
Manufacturer:
LTS Lohmann Therapie-Systeme AG, Andernach, Germany

Product:
Active Ingredient:
Sauflon Multi Preservative Free One Step Multifunction Solution
Hydrogen peroxide 3.5%w/v
Dosage Form:
Contact lens solution
New Zealand Sponsor:
Pharmaceutical Marketing New Zealand Limited
Manufacturer:
Sauflon Pharmaceuticals Limited, Kent, United Kingdom

Dated this 11th day of November 2010.

STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go8811

Renewal of Provisional Consent to the Distribution of a Medicine

Pursuant to section 23(4A) of the Medicines Act 1981, the Minister of Health hereby renews the provisional consent to the sale, supply or use in New Zealand of the medicine set out in the Schedule hereto:

Schedule

Product:
Prothrombinex-VF
Active Ingredients:
Factor II 500IU
Factor IX 500IU
Factor X 500IU
Dosage Form:
Powder for injection
New Zealand Sponsor:
CSL Biotherapies (NZ) Limited
Manufacturer:
CSL Limited, Broadmeadows, Australia
Note: This renewed consent is valid for two years from 3 December 2010.



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2010, No 154





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines

πŸ₯ Health & Social Welfare
11 November 2010
Medicines, Distribution, Consent, Pharmaceuticals
  • STEWART JESSAMINE, Acting Deputy Director-General, Population Health Directorate, Ministry of Health

πŸ₯ Renewal of Provisional Consent to the Distribution of a Medicine

πŸ₯ Health & Social Welfare
Medicines, Renewal, Provisional Consent, Pharmaceuticals